2016
DOI: 10.3389/fimmu.2016.00022
|View full text |Cite
|
Sign up to set email alerts
|

Expression of TLR-7, MyD88, NF-kB, and INF-α in B Lymphocytes of Mayan Women with Systemic Lupus Erythematosus in Mexico

Abstract: BackgroundSystemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease involving multiple organs. It is currently accepted that several genetic, environmental, and hormonal factors are contributing to its development. Innate immunity may have a great influence in autoimmunity through Toll-like receptors. TLR-7 recognizing single-strand RNA has been involved in SLE. Its activation induces intracellular signal with attraction of MyD88 and NF-kBp65, leading to IFN-α synthesis which correlate wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
21
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 57 publications
(42 reference statements)
3
21
0
Order By: Relevance
“… 34 As a common adaptor, MyD88 could interact with interleukin-1receptor-associated kinase 1/4 (IRAK1/4) and TNF receptor-associated factor 6 (TRAF6) through its amino-terminal death domain and induce the activation of NF-κB, thus enhancing the expression of pro-inflammatory factors. 35 , 36 It has been reported that the expression of MyD88 was aberrantly expressed in the B lymphocytes of SLE patients, 37 implying that MyD88 might be involved in the development and process of SLE. As the critical role of MyD88 in inflammatory response, we further investigated whether MyD88 was regulated by miR-145 and was associated with the IL-6-induced increase of sensitivity to UVB irradiation in HaCaT cells.…”
Section: Discussionmentioning
confidence: 99%
“… 34 As a common adaptor, MyD88 could interact with interleukin-1receptor-associated kinase 1/4 (IRAK1/4) and TNF receptor-associated factor 6 (TRAF6) through its amino-terminal death domain and induce the activation of NF-κB, thus enhancing the expression of pro-inflammatory factors. 35 , 36 It has been reported that the expression of MyD88 was aberrantly expressed in the B lymphocytes of SLE patients, 37 implying that MyD88 might be involved in the development and process of SLE. As the critical role of MyD88 in inflammatory response, we further investigated whether MyD88 was regulated by miR-145 and was associated with the IL-6-induced increase of sensitivity to UVB irradiation in HaCaT cells.…”
Section: Discussionmentioning
confidence: 99%
“…Increased mRNA expression of MyD88, TRAF6, and IRAK4 has been demonstrated in PBMCs from SLE patients, which correlated with disease activity (41). Increased expression of MyD88 in B lymphocytes was also found in SLE patients but unlikely to be affected by disease activity (42). Increased expression of MyD88, TRIF, and IRAK has been found in monocytes from patients with T1DM (20, 43).…”
Section: Discussionmentioning
confidence: 99%
“…20 Mayyan women are more suitable to get lupus disease. Pacheo et al 21 assess the role of TLR7, MyD88, and NF-κB p65 in B-lymphocytes of Mayan women with SLE and point out the increased expression of TLR7, MyD88, and NF-κB p65 in B-lymphocytes from Mayan women, which supports its role in the pathogenesis of SLE in this ethnic population of southeast of Mexico.…”
Section: 4mentioning
confidence: 92%